Zimmer Biomet Holdings, Inc.
$94.32
▲
1.76%
2026-04-22 10:12:13
www.zimmerbiomet.com
NYQ: ZBH
Explore Zimmer Biomet Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$18.29 B
Current Price
$94.32
52W High / Low
$108.29 / $84.59
Stock P/E
26.61
Book Value
$64.95
Dividend Yield
1.04%
ROCE
6.61%
ROE
5.6%
Face Value
—
EPS
$3.55
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
17,000
Beta
0.61
Debt / Equity
61.97
Current Ratio
1.98
Quick Ratio
1.1
Forward P/E
10.36
Price / Sales
2.21
Enterprise Value
$25.48 B
EV / EBITDA
10.21
EV / Revenue
3.1
Rating
Hold
Target Price
$103.05
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Lumexa Imaging Holdings, Inc. | $9.65 | — | $928.42 M | — | 1.69% | -12.6% | $19.45 / $7.23 | $6.1 |
| 2. | Artivion, Inc. | $38.8 | 193.48 | $1.89 B | — | 3.41% | 2.7% | $48.25 / $22.22 | $9.37 |
| 3. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 4. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
| 5. | Axogen, Inc. | $37.23 | — | $2 B | — | -3.96% | -13.49% | $39.99 / $9.22 | $2.73 |
| 6. | Sera Prognostics, Inc. | $2.29 | — | $90.03 M | — | -46.95% | -51.83% | $4.09 / $1.37 | $1.94 |
| 7. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.24 B | 2 B | 2.08 B | 1.91 B | 2.02 B | — |
| Operating Profit | 282.6 M | 338.3 M | 396.4 M | 338.9 M | 423.5 M | — |
| Net Profit | 139.3 M | 230.9 M | 152.8 M | 182 M | 239.5 M | — |
| EPS in Rs | 0.72 | 1.19 | 0.79 | 0.94 | 1.24 | 1.23 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 8.23 B | 7.68 B | 7.39 B | 6.94 B |
| Operating Profit | 1.36 B | 1.53 B | 1.45 B | 1.19 B |
| Net Profit | 705.1 M | 903.8 M | 1.02 B | 231.4 M |
| EPS in Rs | 3.64 | 4.67 | 5.29 | 1.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 23.09 B | 21.37 B | 21.5 B | 21.07 B |
| Total Liabilities | 10.39 B | 8.89 B | 9.01 B | 9.04 B |
| Equity | 12.7 B | 12.47 B | 12.48 B | 12.02 B |
| Current Assets | 5.12 B | 4.67 B | 4.61 B | 4.43 B |
| Current Liabilities | 2.58 B | 2.45 B | 2.86 B | 2.36 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.7 B | 1.5 B | 1.58 B | 1.28 B |
| Investing CF | -1.98 B | -888.1 M | -778.9 M | -529.2 M |
| Financing CF | 326 M | -484.5 M | -763.5 M | -843.8 M |
| Free CF | 1.42 B | 1.14 B | 1.19 B | 1.07 B |
| Capex | -276.9 M | -356.8 M | -394.5 M | -217.6 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 3.85% | 6.55% | — | — |
| Earnings Growth % | -11.74% | 342.52% | — | — |
| Profit Margin % | 11.77% | 13.85% | 3.33% | — |
| Operating Margin % | 19.9% | 19.63% | 17.18% | — |
| Gross Margin % | 71.46% | 71.82% | 70.9% | — |
| EBITDA Margin % | 29.31% | 30.03% | 21.54% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-31 | $0.24 |
| 2025-12-30 | $0.24 |
| 2025-09-30 | $0.24 |
| 2025-06-26 | $0.24 |
| 2025-03-31 | $0.24 |
Stock Splits
| Date | Split |
|---|---|
| 2022-03-01 | 1:1.03 |